1 doctor weighed in:
How effective is using oprelvekin for low platelets?
1 doctor weighed in

Dr. Romeo Mandanas
Internal Medicine - Hematology & Oncology
In brief: Better than placebo
The study for which oprevelkin was approved by the fda looked at how good the drug was at preventing need for platelet transfusions following chemotherapy for solid cancers.
It was effective 28-65% of the time vs placebo (7-41%). Because of its mediocre effectivity and a high list of side effects (swelling, irregular heart beat), it is not widely used compared to just giving platelet transfusions.

In brief: Better than placebo
The study for which oprevelkin was approved by the fda looked at how good the drug was at preventing need for platelet transfusions following chemotherapy for solid cancers.
It was effective 28-65% of the time vs placebo (7-41%). Because of its mediocre effectivity and a high list of side effects (swelling, irregular heart beat), it is not widely used compared to just giving platelet transfusions.
Dr. Romeo Mandanas
Dr. Romeo Mandanas
Thank
Read more answers from doctors